Cancer Research

About ten percent of all cases of malignant melanoma are familial cases. The genome of affected families tells scientists a lot about how the disease develops. Prof. Dr. Rajiv Kumar of the German…

In a genome-wide analysis of 13 metastatic prostate cancers done on men who died of metastatic prostate cancer and whose tissue samples were collected after a rapid autopsy, scientists found…

Studies by Ding et al (Cell 2012) revealed that telomerase dysfunction early in disease onset creates genomic aberrations crucial for telomerase-driven prostate cancer metastasis into the lumbar…

Live imaging technology is becoming an increasing popular tool to visualize real-time cellular events in the tumor microenvironment during metastatic progression. In the AACR 2012 symposium…

McCormick Place- Chicago, IL, March 31st- April 4th 2012- was flocked with scientists across the world for the Annual American Association for Cancer Research (AACR) meeting. As with each year, the…

“Personalized medicine! What is that?” Your question is justified.  It was also something that Terry Procter from Peterborough, Ontario thought when he was sent a questionnaire for his opinion…

Wilms' tumors, a type of cancer typically found in the kidneys of young children, might have a new weapon against them. A new therapeutic approach that one day might be used to treat some of the more…

An new American Cancer Society analysis found a strong inverse association between coffee and oral/pharyngeal cancer mortality. Real coffee, not that decaffeinated stuff. The authors say people who…

Blocking a specific protein, ABCC10, renders tumors more vulnerable to treatment in mice ABCC10 is a type of ATP-binding cassette drug efflux pumps, known more simply as ABC proteins. These proteins…

The early results of a trial to treat leukemia with a WT1 DNA vaccine looks promising,  according to a presentation at the DNA Vaccines 2012 conference in California by Christian Ottensmeier,…